GRP
LGND icon

Global Retirement Partners’s Ligand Pharmaceuticals LGND Stock Holding History

Global Retirement Partners’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$79K Buy
418
+182
+77% +$35K ﹤0.01% 2053
2025
Q3 		$41.8K Buy
236
+37
+19% +$5.5K ﹤0.01% 1999
2025
Q2 		$22.6K Buy
+199
New +$21.3K ﹤0.01% 2225
2024
Q4 		$4.5K Buy
42
+26
+163% +$2.94K ﹤0.01% 2729
2024
Q3 		$1.6K Buy
16
+8
+100% +$805 ﹤0.01% 3003
2024
Q2 		$674 Hold
8
– – ﹤0.01% 3246
2024
Q1 		$585 Hold
8
– – ﹤0.01% 3101
2023
Q4 		$569 Buy
+8
New +$472 ﹤0.01% 3049
2022
Q3 		– Sell
-6
Closed – – 2853
2022
Q2 		$0 Hold
6
– – ﹤0.01% 2798
2022
Q1 		$0 Buy
+6
New +$435 ﹤0.01% 2713
2018
Q4 		– Sell
-74
Closed -$13K – 1511
2018
Q3 		$13K Hold
74
– – ﹤0.01% 958
2018
Q2 		$10K Buy
+74
New +$8.26K ﹤0.01% 992
2018
Q1 		– Sell
-42
Closed -$4K – 1519
2017
Q4 		$4K Buy
+42
New +$3.64K ﹤0.01% 1167

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Global Retirement Partners's LGND Position: Q4 2025 in Review

Global Retirement Partners increased its Ligand Pharmaceuticals (LGND) stake by 77% in Q4 2025, buying an estimated $35K and bringing the position to 418 shares worth $79K. The position accounts for ﹤0.01% of the portfolio, ranked #2053.

Global Retirement Partners first reported a position in LGND in Q4 2017 and has held it in 13 quarters since. 349 funds tracked by Wall St. Rank hold LGND as of Q4 2025.

  • Global Retirement Partners held 418 shares of Ligand Pharmaceuticals worth $79K as of Q4 2025.
  • Global Retirement Partners bought 182 Ligand Pharmaceuticals shares in Q4 2025, an estimated $35K.
  • Ligand Pharmaceuticals made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #2053 holding.
  • Global Retirement Partners first reported a position in Ligand Pharmaceuticals in Q4 2017 and has held it in 13 quarters since.
  • 349 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.